$45.96
-1.65 (-3.47%)
At Close: Jul 31, 2026
Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025
08:30am, Friday, 14'th Nov 2025
CAMBRIDGE, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Com
Wall Street Analysts Believe Vericel (VCEL) Could Rally 39.42%: Here's is How to Trade
10:56am, Monday, 10'th Nov 2025
The average of price targets set by Wall Street analysts indicates a potential upside of 39.4% in Vericel (VCEL). While the effectiveness of this highly sought-after metric is questionable, the positi
Vericel Corporation (VCEL) Q3 2025 Earnings Call Transcript
02:46pm, Thursday, 06'th Nov 2025
Vericel Corporation ( VCEL ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants Eric Burns - Vice President of Finance & Investor Relations Dominick C. Colangelo - CEO, President
Brown Capital Discloses $31 Million Sale of Vericel Stock as Small-Cap Biotech Reports Earnings
12:02pm, Thursday, 06'th Nov 2025
Baltimore-based Brown Capital Management sold 861,020 shares of Vericel Corporation in the third quarter for an estimated $31 million. The transaction value represented 1.3% of Brown Capital's 13F rep
Vericel Corporation (VCEL) Q3 Earnings and Revenues Top Estimates
10:10am, Thursday, 06'th Nov 2025
Vericel Corporation (VCEL) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to a loss of $0.02 per share a year ago.
Vericel Reports Third Quarter 2025 Financial Results
07:55am, Thursday, 06'th Nov 2025
Record Third Quarter Total Revenue of $67.5 Million MACI Revenue Growth of 25% to $55.7 Million Net Income of $5.1 Million and Adjusted EBITDA Margin of 25% Record Third Quarter Operating Cash Flow of
Yousif Capital Management LLC Raises Stock Holdings in Vericel Corporation $VCEL
05:22am, Thursday, 23'rd Oct 2025
Yousif Capital Management LLC lifted its holdings in Vericel Corporation (NASDAQ: VCEL) by 2.9% during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC.
Is the Options Market Predicting a Spike in Vericel Stock?
04:51pm, Thursday, 11'th Sep 2025
Investors need to pay close attention to VCEL stock based on the movements in the options market lately.
Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025
08:30am, Thursday, 28'th Aug 2025
CAMBRIDGE, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Com
Vericel Q2 Revenue Jumps 20%
03:14pm, Tuesday, 05'th Aug 2025
Vericel Q2 Revenue Jumps 20%
Vericel Corporation (VCEL) Reports Q2 Loss, Lags Revenue Estimates
10:16am, Thursday, 31'st Jul 2025
Vericel Corporation (VCEL) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.1 per share a year ago.
Vericel Reports Second Quarter 2025 Financial Results
08:08am, Thursday, 31'st Jul 2025
Total Revenue Growth of 20% to $63.2 Million, with MACI Revenue Growth of 21% to $53.5 Million Gross Margin Increased More than 400 Basis Points to 74% Adjusted EBITDA Growth of 112% to $13.4 Million,
Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025
08:30am, Thursday, 17'th Jul 2025
CAMBRIDGE, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Com
Vericel Corporation: Moving From Sell To Neutral
10:23am, Thursday, 12'th Jun 2025
Vericel's valuation has moderated after a 20% share price drop, prompting a shift from sell to neutral. MACI remains the company's primary growth engine, with strong sales momentum and successful surg
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025
08:30am, Tuesday, 10'th Jun 2025
CAMBRIDGE, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Com
Sign In
Buy VCEL